vimarsana.com

Latest Breaking News On - Laboratories private - Page 7 : vimarsana.com

Prasol Chemicals gets SEBI go ahead for IPO

Mumbai-based Prasol Chemicals Limited, amongst the leading forward integrated manufacturers of acetone derivatives and phosphorous derivatives in India, has received the SEBI nod for its Initial Public Offering (IPO).

United statesIndia generalAlembic pharmaceuticalsStar export house companySi groupBayer cropscienceReddy laboratoriesSolvay specialities india privateJm financialAsian paintsCapital advisorsEuropean unionLaboratories privateCoromandel internationalPi industriesOlon active pharmaceutical ingredients india private

MSN Sued Over Patent Infringement Relating to Cabometyx

MSN Sued Over Patent Infringement Relating to Cabometyx
lawstreetmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lawstreetmedia.com Daily Mail and Mail on Sunday newspapers.

United statesExelixis incLaboratories privateDrug administrationPharmaceuticals incPrivate limitedDrug productsTherapeutic equivalence evaluationsPreparing quinoline compounds

Breckenridge Pharmaceutical, Inc Announces Launch of Lacosamide Tablets, USP (generic version of Vimpat®) Manufactured by MSN Laboratories Private Limited

/PRNewswire/ Breckenridge Pharmaceutical, Inc. announces that it has launched Lacosamide Tablets, USP (generic version of Vimpat®). The product was.

United statesAndhra pradeshRobert gasparinoLaboratories privateBreckenridge pharmaceutical incBusiness developmentBreckenridge pharmaceuticalLacosamide tabletsPrivate limitedLacosmide tabletsTowa pharmaceuticalAssociate vice president

Otsuka Files Challenge to ANDA for Low Blood Sodium Treatment

On Thursday a case was filed in the Delaware District Court by Otsuka Pharmaceuticals against MSN Laboratories Private Limited and MSN Pharmaceuticals

United statesOtsuka pharmaceuticalsLaboratories privatePharmaceuticals incDelaware district courtPrivate limitedMorris nichols arsht

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

/PRNewswire/ Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter and full year ended.

United statesMihaelh polymeropoulosKevin moranVanda pharmaceuticals incPrnewswire vanda pharmaceuticals incVanda pharmaceuticals reportsExchange commissionHead of corporate affairsLaboratories privatePharmaceuticals incVanda pharmaceuticals settlesSmith magenis syndromeColorado medicaidPharmaceuticals settlesPatent litigationPharmaceuticals reports results

vimarsana © 2020. All Rights Reserved.